You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Cancer
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
home:diseases:cancer [03.13.2019] – [Recent research] sallieqhome:diseases:cancer [03.13.2019] – [H] sallieq
Line 203: Line 203:
 Note also that the primary ARBs being evaluated, candesartan and telmisartan, have significantly different actions than olmesartan. According to the //in silico// emulations of Dr. Marshall, they are VDR antagonists. Note also that the primary ARBs being evaluated, candesartan and telmisartan, have significantly different actions than olmesartan. According to the //in silico// emulations of Dr. Marshall, they are VDR antagonists.
  
-==== H ====+==== Risk ====
  
 <blockquote>analyses found no evidence that cancer risk increased with increasing duration of ARB exposure (RR increase per year=0.99) <blockquote>analyses found no evidence that cancer risk increased with increasing duration of ARB exposure (RR increase per year=0.99)
home/diseases/cancer.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.